Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8871) 8871
Newsletter (343) 343
Book Chapter (267) 267
Newspaper Article (32) 32
Magazine Article (23) 23
Dissertation (15) 15
Web Resource (9) 9
Book / eBook (7) 7
Publication (6) 6
Conference Proceeding (5) 5
Reference (4) 4
Journal / eJournal (2) 2
Book Review (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6833) 6833
science & technology (5537) 5537
life sciences & biomedicine (5428) 5428
female (3669) 3669
male (3602) 3602
neurosciences & neurology (3008) 3008
magnetic resonance imaging (2705) 2705
clinical neurology (2478) 2478
adult (2395) 2395
leukoencephalopathy (2333) 2333
middle aged (2214) 2214
neurosciences (1652) 1652
progressive multifocal leukoencephalopathy (1577) 1577
neurology (1550) 1550
biological and medical sciences (1515) 1515
medical sciences (1456) 1456
brain - pathology (1438) 1438
aged (1246) 1246
leukoencephalopathy, progressive multifocal - diagnosis (897) 897
leukoencephalopathy, progressive multifocal - pathology (832) 832
abridged index medicus (775) 775
leukoencephalopathies - pathology (754) 754
leukoencephalopathy, progressive multifocal (749) 749
risk factors (746) 746
multiple sclerosis (724) 724
child (691) 691
infectious diseases (675) 675
adolescent (638) 638
jc virus (631) 631
research (624) 624
diagnosis, differential (596) 596
leukoencephalopathy, progressive multifocal - virology (579) 579
leukoencephalopathy, progressive multifocal - etiology (570) 570
mutation (566) 566
brain (528) 528
animals (523) 523
posterior leukoencephalopathy syndrome - diagnosis (521) 521
natalizumab (514) 514
diagnosis (513) 513
neuroimaging (511) 511
leukoencephalopathy, progressive multifocal - complications (504) 504
care and treatment (501) 501
tomography, x-ray computed (489) 489
leukoencephalopathies - genetics (486) 486
pediatrics (480) 480
young adult (469) 469
leukoencephalopathy, progressive multifocal - chemically induced (461) 461
leukoencephalopathies - diagnosis (457) 457
aids/hiv (449) 449
hypertension (449) 449
health aspects (448) 448
medicine & public health (447) 447
patients (441) 441
general & internal medicine (430) 430
immunology (425) 425
retrospective studies (425) 425
child, preschool (423) 423
leukoencephalopathy, progressive multifocal - drug therapy (414) 414
nervous system (406) 406
encephalopathy (405) 405
viral diseases (403) 403
treatment outcome (397) 397
virology (395) 395
viruses (388) 388
medicine, general & internal (386) 386
posterior leukoencephalopathy syndrome - etiology (385) 385
posterior reversible encephalopathy syndrome (379) 379
brain - diagnostic imaging (377) 377
human viral diseases (372) 372
jc virus - isolation & purification (362) 362
medical research (361) 361
jc virus - genetics (355) 355
leukoencephalopathies - etiology (355) 355
genetic aspects (340) 340
psychiatry (337) 337
leukoencephalopathies - diagnostic imaging (335) 335
pathology (325) 325
leukoencephalopathy, progressive multifocal - immunology (322) 322
aged, 80 and over (321) 321
radiology, nuclear medicine & medical imaging (309) 309
magnetic resonance imaging - methods (308) 308
stroke (304) 304
medicine, experimental (303) 303
fatal outcome (300) 300
oncology (299) 299
biopsy (295) 295
surgery (287) 287
nuclear magnetic resonance--nmr (284) 284
infant (283) 283
disease progression (280) 280
substantia alba (279) 279
immunosuppressive agents - adverse effects (277) 277
leukoencephalopathies - complications (268) 268
mri (268) 268
virus diseases (267) 267
case report (265) 265
analysis (262) 262
drug therapy (262) 262
medicine (259) 259
cardiovascular system & cardiology (255) 255
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (8723) 8723
Japanese (285) 285
Spanish (201) 201
French (172) 172
German (131) 131
Portuguese (66) 66
Chinese (39) 39
Russian (36) 36
Polish (24) 24
Italian (23) 23
Turkish (19) 19
Dutch (14) 14
Korean (14) 14
Czech (9) 9
Danish (9) 9
Hungarian (8) 8
Norwegian (5) 5
Swedish (4) 4
Finnish (3) 3
Hebrew (3) 3
Croatian (2) 2
Romanian (2) 2
Greek (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Incidence and Outcome of Progressive Multifocal Leukoencephalopathy over 20 Years of the Swiss HIV Cohort Study
by Nina Khanna and Luigia Elzi and Nicolas J. Mueller and Christian Garzoni and Matthias Cavassini and Christoph A. Fux and Pietro Vernazza and Enos Bernasconi and Manuel Battegay and Hans H. Hirsch and Swiss HIV Cohort Study
Clinical infectious diseases, ISSN 1058-4838, 5/2009, Volume 48, Issue 10, pp. 1459 - 1466
T lymphocytes | HIV/AIDS | Antiretrovirals | HIV | JC virus | Mortality | Cohort studies | AIDS | Death | Carts | Progressive multifocal leukoencephalopathy | Immunopathology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Viral diseases of the nervous system | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Leukoencephalopathy, Progressive Multifocal - therapy | Humans | Male | Treatment Outcome | CD4 Lymphocyte Count | Leukoencephalopathy, Progressive Multifocal - mortality | Incidence | Antiretroviral Therapy, Highly Active | HIV Infections - immunology | Switzerland - epidemiology | HIV Infections - complications | Adult | Anti-HIV Agents - therapeutic use | Female | Leukoencephalopathy, Progressive Multifocal - epidemiology | Cohort Studies | HIV patients | Research | Demographic aspects | Patient outcomes | Leukoencephalopathy, Progressive multifocal | Distribution | Studies | Human immunodeficiency virus--HIV | T cell receptors | Models | Clinical outcomes | Neurological disorders | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned
by Major, Eugene O and Yousry, Tarek A and Clifford, David B
Lancet neurology, ISSN 1474-4422, 05/2018, Volume 17, Issue 5, pp. 467 - 480
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Leukoencephalopathy, Progressive Multifocal - immunology | Leukoencephalopathy, Progressive Multifocal - chemically induced | Humans | Natalizumab - adverse effects | Leukoencephalopathy, Progressive Multifocal - etiology | Leukoencephalopathy, Progressive Multifocal - virology | Immunologic Factors - adverse effects | Multiple Sclerosis - drug therapy | Medical colleges | Medical research | Neurosciences | Multiple sclerosis | Medicine, Experimental | Disease susceptibility | Drug therapy | Molecular biology | Health aspects | Leukoencephalopathy | Brain | Disease | Immunomodulation | Pathogenesis | Central nervous system | Infections | Patients | Progressive multifocal leukoencephalopathy | Magnetic resonance imaging | Surveillance | Demyelination | Binding sites | Deoxyribonucleic acid--DNA | Immune system | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Diagnostic criteria for adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia due to CSF1R mutation
by Konno, T and Yoshida, K and Mizuta, I and Mizuno, T and Kawarai, T and Tada, M and Nozaki, H and Ikeda, S.‐I and Onodera, O and Wszolek, Z. K and Ikeuchi, T
European journal of neurology, ISSN 1351-5101, 01/2018, Volume 25, Issue 1, pp. 142 - 147
diagnostic criteria | adult‐onset leukoencephalopathy with axonal spheroids and pigmented glia | colony‐stimulating factor 1 receptor | alanyl‐transfer RNA synthetase 2 | leukoencephalopathy | pigmented orthochromatic leukodystrophy | hereditary diffuse leukoencephalopathy with spheroids | adult-onset leukoencephalopathy with axonal spheroids and pigmented glia | colony-stimulating factor 1 receptor | alanyl-transfer RNA synthetase 2 | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Leukoencephalopathies - pathology | Diagnosis, Differential | Leukoencephalopathies - genetics | Reproducibility of Results | CADASIL - pathology | Neuroglia - pathology | Humans | Middle Aged | Spheroids, Cellular - pathology | Male | Tomography, X-Ray Computed | CADASIL - genetics | Young Adult | Magnetic Resonance Imaging | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor - genetics | Axons - pathology | Cognition Disorders - etiology | Leukoencephalopathies - diagnosis | Adolescent | CADASIL - diagnosis | Adult | Female | Receptor, Notch3 - genetics | Aged | Genetic aspects | Diagnosis | Ligases | Leukoencephalopathy | Analysis | Transfer RNA | Sensitivity | Macrophage colony-stimulating factor | Colony-stimulating factor | Diagnostic systems | Mutation | Criteria | Spheroids | Genetic screening | Index Medicus | Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP) | pigmented orthochromatic leukodystrophy (POLD) | colony stimulating factor 1 receptor (CSF1R) | alanyl-transfer (t)RNA synthetase 2 (AARS2) | hereditary diffuse leukoencephalopathy with spheroids (HDLS)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy
by Medrano, Chloe and Vergez, Francois and Mengelle, Catherine and Faguer, Stanislas and Kamar, Nassim and Del Bello, Arnaud
Emerging infectious diseases, ISSN 1080-6040, 11/2019, Volume 25, Issue 11, pp. 2145 - 2147
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Leukoencephalopathy, Progressive Multifocal - immunology | Immunomodulation - drug effects | Humans | Leukoencephalopathy, Progressive Multifocal - drug therapy | Leukoencephalopathy, Progressive Multifocal - virology | Nivolumab - therapeutic use | Treatment Outcome | Kidney Transplantation | Leukoencephalopathy, Progressive Multifocal - diagnosis | Transplant Recipients | Antineoplastic Agents, Immunological - pharmacology | Nivolumab - ultrastructure | Antineoplastic Agents, Immunological - therapeutic use | JC Virus | Care and treatment | Kidneys | Leukoencephalopathy, Progressive multifocal | Organ transplant recipients | Belatacept | Transplantation | T cells | HIV infection | Health aspects | Index Medicus | Effectiveness of Immune Checkpoint Inhibitors in Transplant Recipients with Progressive Multifocal Leukoencephalopathy | viruses | T-cell exhaustion | nivolumab | progressive multifocal leukoencephalopathy | JC virus | kidney transplantation | immunosuppression | BK virus | immune checkpoint inhibitors | Research Letter | PML
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
by Bloomgren, Gary and Richman, Sandra and Hotermans, Christophe and Subramanyam, Meena and Goelz, Susan and Natarajan, Amy and Lee, Sophia and Plavina, Tatiana and Scanlon, James V and Sandrock, Alfred and Bozic, Carmen
The New England journal of medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 20, pp. 1870 - 1880
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Infectious diseases | Viral diseases | Biological and medical sciences | Viral diseases of the nervous system | Medical sciences | Human viral diseases | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Multiple Sclerosis, Relapsing-Remitting - immunology | JC Virus - immunology | Natalizumab | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Risk Factors | Male | Antibodies, Viral - blood | Incidence | Young Adult | Leukoencephalopathy, Progressive Multifocal - chemically induced | Adolescent | Product Surveillance, Postmarketing | Adult | Female | Registries | Aged | Drug Therapy, Combination | Child | Leukoencephalopathy, Progressive Multifocal - epidemiology | Dose-response relationship (Biochemistry) | Causes of | Leukoencephalopathy, Progressive multifocal | Studies | Confidence intervals | Multiple sclerosis | Antibodies | Clinical trials | Estimates | Leukoencephalopathy | Patients | Risk factors | Immunosuppressive agents | Progressive multifocal leukoencephalopathy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
by Clifford, David B, MD and DeLuca, Andrea, MD and Simpson, David M, MD and Arendt, Gabriele, MD and Giovannoni, Gavin, MBBCh and Nath, Avindra, MD
Lancet neurology, ISSN 1474-4422, 2010, Volume 9, Issue 4, pp. 438 - 446
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Monoclonal, Humanized | Leukoencephalopathy, Progressive Multifocal - therapy | Natalizumab | Humans | Antibodies, Monoclonal - adverse effects | Leukoencephalopathy, Progressive Multifocal - etiology | Antibodies, Monoclonal - therapeutic use | Immunologic Factors - adverse effects | Leukoencephalopathy, Progressive Multifocal - diagnosis | Leukoencephalopathy, Progressive Multifocal - epidemiology | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy | Medical colleges | Multiple sclerosis | Care and treatment | Leukoencephalopathy, Progressive multifocal | Index Medicus | Cerebrospinal fluid
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Risk of natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: a retrospective analysis of data from four clinical studies
by Ho, Pei-Ran and Koendgen, Harold and Campbell, Nolan and Haddock, Bill and Richman, Sandra and Chang, Ih
Lancet neurology, ISSN 1474-4422, 11/2017, Volume 16, Issue 11, pp. 925 - 933
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | JC Virus - immunology | Multiple Sclerosis - blood | Humans | Middle Aged | Natalizumab - adverse effects | Risk Factors | Kaplan-Meier Estimate | Male | Clinical Studies as Topic | Leukoencephalopathy, Progressive Multifocal - chemically induced | PubMed - statistics & numerical data | Leukoencephalopathy, Progressive Multifocal - etiology | Multiple Sclerosis - immunology | Adult | Antibodies - blood | Female | Immunologic Factors - adverse effects | Cohort Studies | Multiple Sclerosis - drug therapy | Medical research | Care and treatment | Multiple sclerosis | Leukoencephalopathy, Progressive multifocal | Clinical trials | Medicine, Experimental | Risk factors | Immunoglobulins | Statistical analysis | Data processing | Patients | Estimates | Leukoencephalopathy | Progressive multifocal leukoencephalopathy | Studies | Neurology | Algorithms | Risk assessment | Population | Clinical medicine | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
by Cortese, Irene and Muranski, Pawel and Enose-Akahata, Yoshimi and Ha, Seung-Kwon and Smith, Bryan and Monaco, MariaChiara and Ryschkewitsch, Caroline and Major, Eugene O and Ohayon, Joan and Schindler, Matthew K and Beck, Erin and Reoma, Lauren B and Jacobson, Steve and Reich, Daniel S and Nath, Avindra
The New England journal of medicine, ISSN 0028-4793, 04/2019, Volume 380, Issue 17, pp. 1597 - 1605
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Immune Reconstitution Inflammatory Syndrome - etiology | Brain - diagnostic imaging | Humans | Middle Aged | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | CD4-Positive T-Lymphocytes - physiology | Viral Load | Adult | Female | Leukoencephalopathy, Progressive Multifocal - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Down-Regulation | Leukoencephalopathy, Progressive Multifocal - drug therapy | Programmed Cell Death 1 Receptor - metabolism | Cerebrospinal Fluid - virology | CD8-Positive T-Lymphocytes - physiology | White Matter - pathology | Magnetic Resonance Imaging | White Matter - diagnostic imaging | JC Virus - isolation & purification | Lymphocyte Count | Aged | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Immunologic Factors - therapeutic use | Drug therapy | Leukoencephalopathy | Nuclear magnetic resonance--NMR | PD-1 protein | Laboratories | CD8 antigen | Body weight | Immune clearance | Infections | Cerebrospinal fluid | Progressive multifocal leukoencephalopathy | Disability | Pembrolizumab | Lymphocytes | Peripheral blood | Drug dosages | Movement disorders | Antigens | Immune response | Cytokines | Patients | Lymphoma | CD4 antigen | Immune checkpoint | Cell death | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Stratification and monitoring of natalizumab-associated progressive multifocal leukoencephalopathy risk: recommendations from an expert group
by McGuigan, C and Craner, M and Guadagno, J and Kapoor, R and Mazibrada, G and Molyneux, P and Nicholas, R and Palace, J and Pearson, O R and Rog, D and Young, C A
Journal of neurology, neurosurgery and psychiatry, ISSN 0022-3050, 02/2016, Volume 87, Issue 2, pp. 117 - 125
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Surgery | Science & Technology | Guidelines as Topic | Humans | Immunosuppressive Agents - therapeutic use | Natalizumab - adverse effects | Risk | Leukoencephalopathy, Progressive Multifocal - diagnosis | Monitoring, Ambulatory | Multiple Sclerosis - complications | Leukoencephalopathy, Progressive Multifocal - chemically induced | Natalizumab - therapeutic use | Immunosuppressive Agents - adverse effects | Leukoencephalopathy, Progressive Multifocal - epidemiology | Multiple Sclerosis - drug therapy | Viral antibodies | Care and treatment | Practice | Antibodies | Dosage and administration | Leukoencephalopathy | Neurologists | Writing | Immunoglobulins | Decision making | Patients | Technical communication | Mortality | Index Medicus | Multiple Sclerosis | 1506
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights